Air Fluidized Therapy (AFT) in Patients With Suspected Deep Tissue Injury (sDTI)
Air Fluidized Therapy Use in Patients Who Present With Suspected Deep Tissue Injury - a Case Series
1 other identifier
observational
5
1 country
1
Brief Summary
Patients with a suspected Deep Tissue Injury (or a purple reddened area over a bony prominence of their body, which is expected to break down into a pressure ulcer) will be place on the Clinitron® Rite HiteTM bed to see if the air fluidized mattress decreases the amount of tissue breakdown from their bruise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 8, 2011
CompletedFirst Posted
Study publicly available on registry
February 10, 2011
CompletedFebruary 11, 2011
February 1, 2011
6 months
February 8, 2011
February 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of breakdown
This case series seeks to identify patients with suspected DTI and capture actual patient outcomes with AFT treatment
21 days
Interventions
All identified patients will receive a AFT bed for a maximum of 21 days or until discharge
Eligibility Criteria
Patients who present to the hospital with SDTI
You may qualify if:
- Patients with sDTI on the supine aspect of their body
- Patient does not require a pulmonary specialty bed for care
- Patient is expected to be in the hospital for at least 3 days
- Patient weighs between 30 and 350 Lbs.
- Patient's height is less than 75 inches tall
- Patient, or patient's representative, is willing and able to sign written informed consent
- Patient is expected to survive hospitalization.
You may not qualify if:
- Patient is less than 18 years of age
- Patient has already participated in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hill-Romlead
Study Sites (1)
Harris Methodist Hospital
Fort Worth, Texas, 76104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 8, 2011
First Posted
February 10, 2011
Study Start
August 1, 2010
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
February 11, 2011
Record last verified: 2011-02